This page shows the latest Richard Mason news and features for those working in and with pharma, biotech and healthcare.
PME speaks to Richard Mason on how drug discovery is evolving. ... Richard Mason (pictured above) is a veteran of the UK biotech industry, including a spell as CEO of company XO1 set up by venture capital investors Index Ventures (now Medicxi) in
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...